Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma

Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
Juxian Sun
1Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiayi Wu
2Shengli Clinical Medical College, Fujian Medical University, Fuzhou 350001, China
3Department of Hepatobiliary Surgery, Fujian Provincial Hospital, Fuzhou 350001, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang Liu
1Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Shi
1Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonggang Wei
4Department of Hepatobiliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianyin Zhou
5Department of Hepatobiliary Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhibo Zhang
6Department of Hepatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wan Yee Lau
1Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China
7Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maolin Yan
2Shengli Clinical Medical College, Fujian Medical University, Fuzhou 350001, China
3Department of Hepatobiliary Surgery, Fujian Provincial Hospital, Fuzhou 350001, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maolin Yan
  • For correspondence: chengshuqun{at}aliyun.com yanmaolin74{at}163.com
Shuqun Cheng
1Department of Hepatic Surgery VI, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200433, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shuqun Cheng
  • For correspondence: chengshuqun{at}aliyun.com yanmaolin74{at}163.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Kaplan-Meier curves of 6 systems which all showed overlapping survival curves. (A) Kaplan-Meier curves of the Barcelona Clinic Liver Cancer staging. (B) Kaplan-Meier curves of the TNM staging. (C) Kaplan-Meier curves of the CLIP. (D) Kaplan-Meier curves of the JIS. (E) Kaplan-Meier curves of the Ueda classification system. (F) Kaplan-Meier curves of the Japanese B-classification system. All 6 systems showed overlapping survival curves.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Patterns of biliary tumor thrombus type systems. T: hepatic tumor.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Overall survival according to different biliary tumor thrombus types. (A) The median OS of type I and type II. (B) The median DFS of type I and type II.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    Kaplan-Meier curves of the subtypes of the new biliary tumor thrombus types. (A) The median OS of type Ia and type Ib. (B) The median OS of type IIa and type IIb.

Tables

  • Figures
    • View popup
    Table 1

    Survival outcomes of the 6 staging systems

    Current modeln1-year survival3-year survival5-year survivalP
    TNM0.097
     111275.0%28.6%9.8%
     21877.8%44.4%11.1%
     37075.7%24.3%10.0%
     4250.0%00
    JIS score0.002
     0988.9%00
     18883.0%35.2%12.5%
     27171.8%26.8%9.9%
     33259.4%21.9%3.1%
     4250.0%00
    CLIP score0.497
     03797.3%30.6%13.5%
     18668.6%37.3%10.5%
     24475.0%48.5%9.1%
     33070.0%33.3%3.3%
     4560.0%33.3%0
    BCLC stage0.375
     A6572.3%35.4%10.8%
     B9978.8%25.3%9.1%
     C3871.1%23.7%7.9%
    B-classification0.009
     110100.0%20.0%10.0%
     22596.0%52.0%32.0%
     33482.4%32.4%23.5%
     413367.7%23.3%1.5%
    Ueda-classification0.001
     13597.1%42.9%25.7%
     23482.4%32.4%23.5%
     312469.4%25.0%1.6%
     4520.0%00
     5425.0%00
    • View popup
    Table 2

    Univariate analysis and multivariate analysis of overall survival

    VariableUnivariate analysisMultivariate analysis
    β95%CIPβ95%CIP
    Age (years) < 500.0031.003 (0.714–1.409)0.085
    Gender (N), male: female0.1311.140 (0.710–1.829)0.589
    AFP (μg/L), < 400: ≥ 400−0.1950.823 (0.589–1.150)0.254
    ALT (U/L), < 40: ≥ 40−0.0250.976 (0.674–1.413)0.897
    Total bilirubin (μmol/L) > 3000.9052.472 (1.461–4.183)0.0010.732.075 (1.210–3.559)0.008
    Hbs Ag (N), positive: negative0.0791.082 (0.681–1.721)0.738
    HBV-DNA (copies/mL) < 1,0000.1241.122 (0.764–1.680)0.536
    Tumor number, single0.0551.056 (0.740–1.508)0.764
    Tumor diameter, < 5 cm−0.0390.962 (0.686–1.348)0.821
    Coexistence of PVTT0.3781.460 (0.983–2.167)0.061
    Child-Pugh A:B0.4341.543 (1.106–2.154)0.0110.0661.068 (0.700–1.631)0.759
    ALP < 135 U/L0.2151.240 (0.870–1.766)0.234
    GGT < 45 U/L1.283.596 (0.887–14.576)0.073
    PT < 13 S0.2071.230 (0.857–1.766)0.261
    BDTT, Intrahepatic: extrahepatic0.5551.743 (1.207–2.516)0.0030.471.600 (1.097–2.332)0.015
    Anatomic: local resection0.321.377 (0.989–1.918)0.058
    • View popup
    Table 3

    The clinicopathological features of the 2 types of biliary tumor thrombus patients

    VariableType I (n = 69)Type II (n = 133)P
    Age51.3 ± 11.052.9 ± 10.20.512
    Gender (N), male:female53/16117/160.039
    AFP (μg/L), < 400: ≥ 40033/3676/570.208
    ALT (U/L), < 40: ≥ 4030/3923/1100.001
    Total bilirubin (μmol/L)25.97 ± 44.1135.3 ± 123.90.001
    ALP (U/L)147.9 ± 73.0262.5 ± 153.10.001
    PT (S)12.1 ± 1.012.5 ± 1.30.079
    Hbs Ag (N), positive: negative62/7111/220.219
    HBV-DNA (copies/mL)0.479
    < 1,00052106
    ≥ 1,0001727
    Tumor number, single: multiple45/2493/400.495
    Tumor diameter (cm)7.34 ± 5.085.52 ± 3.350.052
    Coexistence of PVTT (n)18/6923/1330.148
    Child-Pugh A:B65/452/810.001
    Anatomic/local resection41/2863/700.104
    • View popup
    Table 4

    Survival outcomes of the 2 biliary tumor thrombus subtypes

    TypesType I: intrahepatic BTTPType II: extrahepatic BTTP
    SubtypesType Ia: tumor thrombosis involving the second-order intrahepatic duct or aboveType Ib: tumor thrombosis involving the first-order intrahepatic ductType IIa: TB < 300 μmol/LType IIb: TB > 300 μmol/L
    OS (%)0.0700.023
    1-year97.1%82.4%68.4%62.5%
    3-year42.9%32.4%24.8%12.5%
    OS (month)44.430.423.917.4
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 18 (3)
Cancer Biology & Medicine
Vol. 18, Issue 3
1 Aug 2021
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan, Shuqun Cheng
Cancer Biology & Medicine Aug 2021, 18 (3) 808-815; DOI: 10.20892/j.issn.2095-3941.2020.0202

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan, Shuqun Cheng
Cancer Biology & Medicine Aug 2021, 18 (3) 808-815; DOI: 10.20892/j.issn.2095-3941.2020.0202
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Grant support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4/CCL2 signaling pathway
  • Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer
  • Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma
Show more Original Article

Similar Articles

Keywords

  • hepatocellular carcinoma
  • biliary tumor thrombus
  • staging system
  • surgery
  • prognosis

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire